Promise without Practice — Charting the Path Forward for Bladder Cancer Biomarkers

Promise without practice — charting the path forward for bladder cancer biomarkers

Bladder cancer is a biologically heterogeneous disease, and ongoing efforts in biomarker research aim to support personalized treatment approaches. Circulating tumour DNA is approaching clinical integration through prospective trials, whereas other markers remain investigational owing to technical limitations, inconsistent findings and lack of validation. Rigorous biomarker-driven trials and cost-effectiveness studies are needed to enable the in…

Bladder Cancer in India: How early detection and multidisciplinary approach can treat this disease

You spot blood in your urine. It doesn't hurt, it doesn't happen again, and you assume it's nothing. But what if that tiny symptom is your body's red alert, trying to tell you something serious? Bladder cancer (cancer of the urinary bladder) often whispers before it strikes, and this is where timely care, early diagnosis, and, most importantly, a team-based approach can change outcomes dramatically. Bladder Cancer: An increasingly recognised dan…

In the Pipeline: Novel Treatment Delivery Methods for NMIBC

Panelists discuss novel intravesical drug delivery systems like TAR-200 and UGN-102 that enhance chemotherapy exposure and efficacy in non–muscle-invasive bladder cancer (NMIBC), while noting challenges in tolerability and administration, and highlighting their potential to improve patient outcomes and reduce invasive procedures.

MHRA approves nogapendekin alfa inbakicept to treat adult patients with non-muscle invasive bladder cancer

Open the article to view the coverage from uk-times.com

The future of bladder cancer care: Can latest medical advances make a difference?

New Delhi: With their medical innovations, the researchers have paved the way for advanced treatment options for bladder cancer. From personalised immunotherapies and targeted drug treatment to minimally invasive surgical techniques, the scope of care for bladder cancer patients is rapidly evolving. This article uncovers the latest medical advances that can regain the lost hopes of patients who have bladder cancer and help them discover how mode…

TAR-200 Offers New Hope for BCG-Unresponsive Bladder Cancer

Joseph Jacob, MD, discusses the promising impact of TAR-200.